We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$393M
AUM Growth
+$20.1M
Cap. Flow
+$9.32M
Cap. Flow %
2.37%
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
109
Reduced
91
Closed
395

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.3M
2
MRNA icon
Moderna
MRNA
+$5.95M
3
QCOM icon
Qualcomm
QCOM
+$4.24M
4
TAL icon
TAL Education Group
TAL
+$3.82M
5
AMD icon
Advanced Micro Devices
AMD
+$3.65M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$3.44M
2
KMB icon
Kimberly-Clark
KMB
+$2.7M
3
MCO icon
Moody's
MCO
+$2.68M
4
UPS icon
United Parcel Service
UPS
+$2.64M
5
SHW icon
Sherwin-Williams
SHW
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 17.91%
2 Technology 17.83%
3 Consumer Discretionary 11.15%
4 Industrials 9.32%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
326
United Therapeutics
UTHR
$26.3B
$399K 0.1%
+2,225
New +$424K
UMC icon
327
United Microelectronic
UMC
$47.9B
$397K 0.1%
+41,976
New +$393K
BWXT icon
328
BWX Technologies
BWXT
$16.2B
$396K 0.1%
+6,822
New +$439K
SONO icon
329
Sonos
SONO
$1.87B
$394K 0.1%
11,178
+4,646
+71% +$174K
MRK icon
330
Merck
MRK
$323B
$392K 0.1%
+5,042
New +$375K
SMH icon
331
VanEck Semiconductor ETF
SMH
$66.1B
$392K 0.1%
+2,990
New +$369K
ELV icon
332
Elevance Health
ELV
$82.1B
$391K 0.1%
+1,024
New +$391K
FNF icon
333
Fidelity National Financial
FNF
$14B
$391K 0.1%
9,359
+1,428
+18% +$62.4K
CPNG icon
334
Coupang
CPNG
$28.6B
$388K 0.1%
+9,275
New +$380K
ASX icon
335
ASE Group
ASX
$80.2B
$387K 0.1%
+48,073
New +$387K
K
336
DELISTED
Kellanova
K
$387K 0.1%
+6,408
New +$389K
SU icon
337
Suncor Energy
SU
$75.6B
$380K 0.1%
15,837
-25,962
-62% -$596K
ICLN icon
338
iShares Global Clean Energy ETF
ICLN
$2.35B
$377K 0.1%
16,051
-15,631
-49% -$357K
SIGI icon
339
Selective Insurance
SIGI
$5.53B
$377K 0.1%
+4,642
New +$355K
UHS icon
340
Universal Health Services
UHS
$9.64B
$377K 0.1%
2,574
+939
+57% +$142K
VWO icon
341
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$376K 0.1%
6,930
-13,874
-67% -$739K
CB icon
342
Chubb
CB
$139B
$372K 0.09%
2,343
-4,246
-64% -$704K
VXF icon
343
Vanguard Extended Market ETF
VXF
$30.5B
$369K 0.09%
1,959
-436
-18% -$79.7K
TRP icon
344
TC Energy
TRP
$71.2B
$368K 0.09%
7,423
-16,048
-68% -$803K
BBD icon
345
Banco Bradesco
BBD
$38.5B
$367K 0.09%
+78,619
New +$342K
BF.B icon
346
Brown-Forman Class B
BF.B
$12.6B
$367K 0.09%
4,900
+315
+7% +$24K
AMED
347
DELISTED
Amedisys
AMED
$366K 0.09%
1,494
+518
+53% +$136K
MGA icon
348
Magna International
MGA
$18.3B
$364K 0.09%
+3,928
New +$374K
CNXC icon
349
Concentrix
CNXC
$1.5B
$363K 0.09%
+2,260
New +$348K
DBRG icon
350
DigitalBridge
DBRG
$2.93B
$363K 0.09%
11,473
+7,528
+191% +$215K

Similar funds

Y-Intercept (HK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Y-Intercept (HK) held 983 positions worth $393M, up 5.4% from $373M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Y-Intercept (HK)'s Q2 2021 filing shows 387 new, 109 increased, 91 reduced and 395 closed positions. Its largest new stake was Linde: 42,339 shares worth $12.2M. The largest sale was Baidu, an estimated $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Y-Intercept (HK)'s largest Q2 2021 buy was Linde: 42,339 shares worth $12.2M.
  • Y-Intercept (HK) added most to Moderna in Q2 2021, an estimated $5.95M increase.
  • Y-Intercept (HK)'s biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $2.59M.
  • Y-Intercept (HK) fully exited Baidu in Q2 2021, selling an estimated $3.44M.
  • Y-Intercept (HK)'s ten largest holdings make up 15% of its $393M portfolio in Q2 2021.
  • Y-Intercept (HK) opened 387 new positions and closed 395 in Q2 2021.
  • Y-Intercept (HK)'s portfolio value rose 5.4% quarter-over-quarter to $393M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.